Skip to main content
. 2020 Dec 16;6(2):100616. doi: 10.1016/j.adro.2020.10.028

Table 2.

Tumor location and subtype for all patients

Patient number Age/sex Type of skin cancer Location Subtype
1 86/M SCC Scalp In situ
2 88/M BCC Scalp Nodular
3 58/F BCC Nose Nodular
4 75 SCC Nose In situ
5 70/F BCC Nose Nodular
6 80/M SCC Left superior parietal scalp Focally pseudoglandular
7 74/F BCC Nose Nodular
8 52/F BCC Left nasal sidewall Nodular
9 51/F BCC Left nasal ala Nodular
10 67/F BCC Nasolabial fold Nodular
11 76/M BCC Nasal supratip Nodular
12 91/M BCC Right inferior vermillion lip Nodular
13 44/F BCC Left upper nasal bridge Nodular
14 77/M BCC Right forehead,
Left nose
Nodular ulcerated
Ulcerated
15 92/F BCC Left central parietal scalp Pigmented nodular
16 93/M BCC Left nasal ala Nodular
17 92/M BCC Right upper lip Nodular
18 62/F BCC Nasal tip Nodular and ulcerated
19 60/F BCC Left nose Nodular

Abbreviations: BCC = basal cell carcinoma; SCC = squamous cell carcinoma.